Found: 2

Select item for more details and to access through your institution.

  • BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

    Published in:
    Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aax2625
    By:
    • Coussy, Florence;
    • El-Botty, Rania;
    • Château-Joubert, Sophie;
    • Dahmani, Ahmed;
    • Montaudon, Elodie;
    • Leboucher, Sophie;
    • Morisset, Ludivine;
    • Painsec, Pierre;
    • Sourd, Laura;
    • Huguet, Léa;
    • Nemati, Fariba;
    • Servely, Jean-Luc;
    • Larcher, Thibaut;
    • Vacher, Sophie;
    • Briaux, Adrien;
    • Reyes, Cécile;
    • La Rosa, Philippe;
    • Lucotte, Georges;
    • Popova, Tatiana;
    • Foidart, Pierre
    Publication type:
    Article

  • Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial.

    Published in:
    Frontiers in Genetics, 2014, v. 5, p. 1, doi. 10.3389/fgene.2014.00152
    By:
    • Servant, Nicolas;
    • Roméjon, Julien;
    • Gestraud, Pierre;
    • La Rosa, Philippe;
    • Lucotte, Georges;
    • Lair, Séverine;
    • Bernard, Virginie;
    • Zeitouni, Bruno;
    • Coffin, Fanny;
    • Jules-Clément, Gérôme;
    • Yvon, Florent;
    • Lermine, Alban;
    • Poullet, Patrick;
    • Liva, Stéphane;
    • Pook, Stuart;
    • Popova, Tatiana;
    • Barette, Camille;
    • Prud'homme, François;
    • Dick, Jean-Gabriel;
    • Kamal, Maud
    Publication type:
    Article